The ONCO/REVEAL Solid Tumor Cancer Panel is a comprehensive targeted approach to multiple gene regions across numerous solid tumor cancer types. Targeting a total of 56 genes, the Solid Tumor Cancer Panel content is based on data across consortia and organizations such as the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), the National Comprehensive Cancer Network (NCCN), and Catalog Of Somatic Mutations In Cancer (COSMIC) database, in addition to ongoing clinical trials.
- Start from as low as 2.5ng
- Detection of 1% allele frequency in somatic cancers
- Single pool design for increased sensitivity
- Automatable single-well processing